1672-1535
2008 Issue 2
bang zuo shi ge xi bao liu 1 li
li yan song ; zhao chun zuo ; chai guan xue
li yan song ; zhao chun zuo ; chai guan xue
..............page:197-199
..............page:插页
bao bi jia qiang nei zhi liao e xing xiong qiang ji ye de lin chuang liao xiao guan cha
lin yan ; yang shun e
lin yan ; yang shun e
..............page:202-204
gui tou e xing lin ba liu 1 li
mao wei ; qiu hui min ; zheng jun hua ; wang yi ; yu gen pei ; xu qing
mao wei ; qiu hui min ; zheng jun hua ; wang yi ; yu gen pei ; xu qing
..............page:200-201
Pharmacokinetical study of interstitial chemotherapy with PLGA-gemcitabine microsphere
li jing quan ; zhao ping ; wang shi liang ; tang zhi qiang ; yang mei ; liu chao yang ; zhang wei
li jing quan ; zhao ping ; wang shi liang ; tang zhi qiang ; yang mei ; liu chao yang ; zhang wei
..............page:191-196
Effects of Shenhong alliance chemotherapeutic drugs in 393 cancer patients
Huang Aiqiang;Ye Haihong;Liang Shuiting;Huang Shunrong;Lan Biyang;Qin Qianzi
Huang Aiqiang;Ye Haihong;Liang Shuiting;Huang Shunrong;Lan Biyang;Qin Qianzi
..............page:185-190,180
Analysis of efficacy of chemotherapy combined with radiotherapy in middle and advanced cervical cancer
Huang Jian;Ye JinJun;Lu Emei
Huang Jian;Ye JinJun;Lu Emei
..............page:181-184
Clinical analysis of paclitaxel liposome combined with carboplatin in the treatment of advanced epithelial ovarian cancer
Lu Weidong;Zuo Yun
Lu Weidong;Zuo Yun
..............page:177-180
Clinical application of ultrasound-guided percutaneous microwave coagulation of hepatic tumors adjacent to the gallbladder
Li Meng;Yu Xiaoling;Liang Ping;Cao Xiaolin;Fan Jin;Liu Fangyi
Li Meng;Yu Xiaoling;Liang Ping;Cao Xiaolin;Fan Jin;Liu Fangyi
..............page:172-176
p16 zai bi yan ai zhong de yan jiu jin zhan
hu jun li ; zhang yue fei
hu jun li ; zhang yue fei
..............page:169-171,176
Current status in treatment of esophagus carcinoma with neoadjuvant and adjuvant chemotherapy
Liu Aina;Li Yusheng;Huang Jing
Liu Aina;Li Yusheng;Huang Jing
..............page:163-168
1,4-n- yi zuo ban ru tang an zhuan yi mei de biao da diao jie ji qi zai jian ce zhong liu wei zhuan yi zhong de ying yong yan jiu
zuo ming jin ; qin feng zhan
zuo ming jin ; qin feng zhan
..............page:157-162
Advances in ribonucleotide reductase subunit M1 and excision repair cross-complementing 1 in the treatment of non-small-cell lung cancer
Luo Yang;Feng Fengyi
Luo Yang;Feng Fengyi
..............page:152-156
Advances in tumor-associated immunosuppressive cells and mechanism of immune escape
Jiao Guohui;Yang Rongcun
Jiao Guohui;Yang Rongcun
..............page:147-151
Single nucleotide polymorphisms and therapeutic radiation sensitivity
Zhang Li;Wang Lvhua
Zhang Li;Wang Lvhua
..............page:141-146,162
Abnormal expression of E-cadherin in breast cancer and its significance
Li Lan;Yang Hongying
Li Lan;Yang Hongying
..............page:135-140
Advances of molecular characteristics and treatment in triple negative breast cancers
waug Xiaojia;Kevin R.Fox
waug Xiaojia;Kevin R.Fox
..............page:129-134
Treatment for elderly lymphoma patients
Li Bo;Shi Yuankai
Li Bo;Shi Yuankai
..............page:122-128
fang xiang hua mei yi zhi ji zai jue jing hou ru xian ai fu nv nei fen mi zhi liao de ce lue
li hui ping
li hui ping
..............page:117-121
Analyses on the differentially expressed genes associated with murine double minute 2/p53 pathway in breast cancer
ba yan hua ;li huiping; li hui ping ; zhao hong mei ; wang jing ; hou kuan yong
ba yan hua ;li huiping; li hui ping ; zhao hong mei ; wang jing ; hou kuan yong
..............page:110-116
Assessment of neoadjuvant chemotherapy for breast cancer in 40 patients
xiao yu ;li huiping; li hui ping ; hou kuan yong ; zhao hong mei ; wang jing ; wang mo pei ; cao bao shan
xiao yu ;li huiping; li hui ping ; hou kuan yong ; zhao hong mei ; wang jing ; wang mo pei ; cao bao shan
..............page:104-109
zui xin dong tai
gu liang jun
gu liang jun
..............page:101-103